Cargando…
Real-World Data on Potent P2Y12 Inhibition in Patients with Suspected Chronic Coronary Syndrome, Referred for Coronary Angiography
INTRODUCTION: Potential benefit with potent platelet inhibition in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI) has been discussed. The aim of this study was to compare a potent P2Y12 inhibition strategy using ticagrelor with clopidogrel in CCS pa...
Autores principales: | Träff, Erik, Venetsanos, Dimitrios, Alpkvist, Karin, Sederholm Lawesson, Sofia, Skibniewski, Mikolaj, Zwackman, Sammy, Alfredsson, Joakim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808708/ https://www.ncbi.nlm.nih.gov/pubmed/36215960 http://dx.doi.org/10.1159/000527459 |
Ejemplares similares
-
Which Females Have the Highest Rates of Depression and Anxiety Following Acute Coronary Syndrome?
por: Thompson, David R.
Publicado: (2023) -
Development and Internal Validation of a Practical Model to Identify Observe Patients of the European Society of Cardiology 0/1-h Algorithm at Low Risk of a Coronary Diagnosis
por: Arslan, Murat, et al.
Publicado: (2022) -
Glomerular filtration rate (GFR) during and after STEMI: a single-centre, methodological study comparing estimated and measured GFR
por: Venetsanos, Dimitrios, et al.
Publicado: (2015) -
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
por: Kristensen, Anna Meta Dyrvig, et al.
Publicado: (2022) -
Metformin Can Be Safely Used in Patients Exposed to Contrast Media: A Systematic Review and Meta-Analysis
por: Qiao, Hua, et al.
Publicado: (2022)